BioMed Central Ltd. / Google / Creative Commons / Takeda Pharmaceuticals / /
Country
Germany / France / United States / / /
Facility
Wake Forest Baptist Medical Center / /
IndustryTerm
literature search / Diabetes Care / online submission / /
MedicalCondition
Lymph node metastases / Tumor stage Background Peroxisome-proliferator-activator-receptor / cancers / human transitional bladder cancer / CV disease / tumor / insulin resistance / muscle invasive disease / human urinary bladder carcinoma / insulin-dependent diabetes mellitus / Cancer / tumors / invasive disease / urolithiasis / higher-grade tumors / bladder cancer / human bladder tumor / cardiovascular disease / diabetes / J Cancer / non-fatal myocardial infarction / Pulmonary disease / positive disease / DM diabetes mellitus / bladder tumors / urothelial carcinogenesis / bladder cancers / increased cancer / developed bladder tumors / II diabetes / /
MedicalTreatment
adjuvant therapies / /
Organization
US Food and Drug Administration / Wake Forest Baptist Medical Center / United States Federal Drug Administration / Department of Urology / Wake Forest University Health Sciences Institutional Review Board / /
Person
Van Troostenburg De Bruyn / Van Vleet / Winston Salem / /
An upper limit for macromolecular crowding effects